Purchase of Actavis saves 300 local jobs

Lincolnton pharmaceutical manufacturer Actavis was recently purchased by New Jersey-based G&W Laboratories Inc. The Lincoln Economic Development Association said the sale will save 300 local jobs that were scheduled to end by mid-2015.

By Adam Orr

Published: Tuesday, June 17, 2014 at 03:39 PM.

The sale of Lincolnton’s Actavis labs to a New Jersey-based pharmaceutical manufacturer will save up to 300 local jobs, according to purchaser G&W Laboratories.

G&W confirmed the purchase Tuesday following months of negotiation. While the company wouldn’t say how much it paid — Lincoln County values the 13.5 acre plot and building at more than $4.1 million — G & W did say it expects to invest an additional $3.5 million in machinery and equipment at the plant on Kawai Road that could result in future job expansion.

G&W CEO Ron Greenblatt said the company was excited about the opportunity to expand its operations through the deal.

“We look forward to a long and mutually beneficial relationship here in Lincoln County and are grateful to have partnered with the county to make our vision a reality,” Greenblatt said.

G&W said the purchase will help it expand its product portfolio.

Negotiations between the two companies, facilitated in part by LEDA, began after Actavis announced its plan in November to close its Lincolnton operation gradually by mid-2015, a move the company said would cost 310 local workers their jobs.

Based in South Plainfield, NJ, family owned G&W Laboratories Inc., was founded in 1919 by Carl Greenblatt and manufactures anti-inflammatory, anti-fungal and topical creams and ointments, among other products.

Reader comments posted to this article may be published in our print edition. All rights reserved. This copyrighted material may not be re-published
without permission. Links are encouraged.

The sale of Lincolnton’s Actavis labs to a New Jersey-based pharmaceutical manufacturer will save up to 300 local jobs, according to purchaser G&W Laboratories.

G&W confirmed the purchase Tuesday following months of negotiation. While the company wouldn’t say how much it paid — Lincoln County values the 13.5 acre plot and building at more than $4.1 million — G & W did say it expects to invest an additional $3.5 million in machinery and equipment at the plant on Kawai Road that could result in future job expansion.

G&W CEO Ron Greenblatt said the company was excited about the opportunity to expand its operations through the deal.

“We look forward to a long and mutually beneficial relationship here in Lincoln County and are grateful to have partnered with the county to make our vision a reality,” Greenblatt said.

G&W said the purchase will help it expand its product portfolio.

Negotiations between the two companies, facilitated in part by LEDA, began after Actavis announced its plan in November to close its Lincolnton operation gradually by mid-2015, a move the company said would cost 310 local workers their jobs.

Based in South Plainfield, NJ, family owned G&W Laboratories Inc., was founded in 1919 by Carl Greenblatt and manufactures anti-inflammatory, anti-fungal and topical creams and ointments, among other products.